0000000000729578

AUTHOR

Eunice Sirri

showing 5 related works from this author

Survival for patients with rare haematologic malignancies: Changes in the early 21st century

2017

Abstract Introduction Population-level survival has improved for common haematologic malignancies in the early 21st century. However, relatively few population-level data are available for rare haematologic malignancies. Methods Data were extracted from 12 cancer registries in Germany and the Surveillance, Epidemiology and End Results database in the United States (US). Cases of haematologic malignancies with an incidence of less than 1 per 100,000 were selected for analysis. Period analysis was used to determine 5-year relative survival (RS) for the years 2003–2012, and modelled period analysis was used to determine changes in survival between 2003–2007 and 2008–2012. Results Seven individ…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyPathologyTime FactorsAdolescentAnaplastic LymphomaYoung Adult03 medical and health sciencesRare Diseases0302 clinical medicineGermanyInternal medicineHumansMedicineRegistriesHealthcare DisparitiesYoung adultSurvival analysisAgedMycosis fungoidesRelative survivalbusiness.industryIncidenceIncidence (epidemiology)CancerMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesTreatment OutcomeOncologyHematologic Neoplasms030220 oncology & carcinogenesisFemaleMantle cell lymphomabusinessSEER Program030215 immunologyEuropean Journal of Cancer
researchProduct

Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States

2016

Objectives Survival improvement for pancreatic cancer has not been observed in the last 4 decades. We report the most up-to-date population-based relative survival (RS) estimates and recent trends in Germany and the United States. Methods Data for patients diagnosed in 1997 to 2010 and followed up to 2010 were drawn from 12 population-based German cancer registries and the US SEER (Surveillance, Epidemiology and End Results) 13 registries database. Using period analysis, 5-year RS for 2007 to 2010 was derived. Model-based period analysis was used to assess 5-year RS time trends, 2002-2010. Results In total 28,977 (Germany) and 34,793 (United States) patients aged 15 to 74 years were analyze…

AdultMalemedicine.medical_specialtyPathologyAdolescentEndocrinology Diabetes and MetabolismPopulationYoung Adult03 medical and health sciencesAge DistributionSex Factors0302 clinical medicineEndocrinologyGermanyPancreatic cancerEpidemiologyInternal MedicineHumansMedicineRegistriesYoung adulteducationSurvival analysisAgedNeoplasm StagingAged 80 and overeducation.field_of_studyHepatologyRelative survivalbusiness.industryAge FactorsCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUnited StatesPancreatic NeoplasmsSurvival Rate030220 oncology & carcinogenesisPeriod AnalysisFemale030211 gastroenterology & hepatologybusinessSEER ProgramDemographyPancreas
researchProduct

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCO…

2022

BACKGROUND Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0-14 years) and adults (aged 15-99 years) diagnosed with a haematological malignancy during 2000-14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0-24 years). METHODS We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3 that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0-14 years), adolescents (15-19 years), and young adults (20-24 years). We categorised leukaemia subtypes a…

AdolescentAustralia610 Medicine & healthlymphomaSettore MED/42 - Igiene Generale E ApplicatasurvivalUnited StatesEuropeLeukemia Myeloid AcuteYoung Adultchildrenpopulation-based/cancer registry360 Social problems & social servicessurvival leukemia cancer registryHematologic NeoplasmsleukaemiaPediatrics Perinatology and Child HealthDevelopmental and Educational PsychologycancerHumansRegistrieshaematological malignancy610 Medicine & healthChild360 Social problems & social services
researchProduct

Survival of patients with gastric lymphoma in Germany and in the United States

2015

Background and Aim This study aims to examine survival for gastric lymphomas and its main subtypes, mucosa-associated lymphoid tissue lymphoma (MALT), and diffuse large B-cell lymphoma (DLBCL), in Germany and in the United States. Methods Data for patients diagnosed in 1997–2010 were used from 10 population-based German cancer registries and compared to the data from the US Surveillance, Epidemiology and End Results (SEER) 13 registries database. Patients age 15–74 diagnosed with gastric lymphomas were included in the analysis. Period analysis and modeled period analysis were used to estimate 5-year and 10-year relative survival (RS) in 2002–2010 and survival trends from 2002–2004 to 2008–2…

medicine.medical_specialtyeducation.field_of_studyHepatologyRelative survivalbusiness.industryGastric lymphomaPopulationGastroenterologymedicine.diseaseGastroenterologySurgeryCancer registryLymphomaimmune system diseaseshemic and lymphatic diseasesInternal medicineMedicinebusinesseducationMucosa-associated lymphoid tissueDiffuse large B-cell lymphomaSurvival rateJournal of Gastroenterology and Hepatology
researchProduct

Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States

2020

Background: Breast cancer treatment has changed tremendously over the last decades. In addition, the use of mammography screening for early detection has increased strongly. To evaluate the impact of these developments, long-term trends in incidence, mortality, stage distribution and survival were investigated for Germany and the United States (US). Methods: Using population-based cancer registry data, long-term incidence and mortality trends (1975&ndash

trendsCancer ResearchUnited States ; Survival ; Trends ; Mortality ; Incidence ; Breast cancer ; GermanyBreast cancer mortalityPopulationsurvivallcsh:RC254-282Article03 medical and health sciencesbreast cancer0302 clinical medicineBreast cancerGermanyMedicine030212 general & internal medicineStage (cooking)Mortality trendseducationeducation.field_of_studyRelative survivalbusiness.industryIncidence (epidemiology)lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemortalityUnited StatesCancer registryOncology030220 oncology & carcinogenesisincidencebusinessDemographyCancers
researchProduct